Overview

This anonymized opportunity concerns a founder-led, multi-site private hospital platform serving the Delhi-NCR region. According to owner-authorized materials dated December 2025, the platform operates multi- and super-specialty facilities and is expanding capacity across its existing network and a planned additional hospital.

Transaction structure and use of funds

The opportunity is presented as a growth equity investment. The supplied materials do not specify the current raise amount, valuation, equity stake, investor rights, governance package or definitive use-of-proceeds allocation. The business plan indicates that capital is intended to support hospital capacity expansion, advanced medical equipment, specialist recruitment, new service lines and working capital. All terms remain subject to confirmation and definitive documentation.

Investment highlights

• Owner materials report consolidated FY25 revenue of approximately INR 2.0 billion and EBITDA of approximately INR 0.5 billion, representing an EBITDA margin of about 25%.
• The platform had roughly 200 operating beds in FY25 and the owner plan models more than 700 operating beds after the current expansion programme.
• Clinical focus includes internal medicine and higher-acuity specialties such as neuroscience, cardiology, gastroenterology, pulmonology, renal sciences, orthopaedics and oncology.
• The operating model combines hospital care, referral networks, community outreach, digital patient acquisition and planned technology-enabled patient services.
• Owner projections model consolidated revenue growth of approximately 32% CAGR from FY25 to FY30, with near-term margin compression during commissioning followed by modeled EBITDA-margin recovery. These are forecasts, not assured outcomes.

Market context

India’s Ministry of Health and Family Welfare estimates total health expenditure at INR 9.04 trillion for 2021-22, or 3.83% of GDP, with household out-of-pocket expenditure representing 39.4% of total health expenditure. The National Health Mission also maintains infrastructure and quality standards for hospital facilities. These system-level sources provide context only and do not validate the company, transaction or projections.

Execution milestones and operating model

The owner plan calls for phased commissioning of expanded capacity, greater emphasis on higher-value specialties, increased cash and insured-patient participation, specialist hiring and additional technology deployment. Timing, capex, regulatory approvals, accreditation scope and ramp-up assumptions require independent technical and commercial diligence.

Ideal investor

This opportunity may suit healthcare-focused private equity, growth equity, family offices or strategic investors able to evaluate hospital expansion, clinical governance, regulatory compliance, doctor recruitment, payor mix, working-capital intensity and multi-year execution risk in India. It is not suitable for investors requiring liquid securities or independently audited forward projections at the initial screening stage.

Material risks and dependencies

• The current raise amount, valuation, dilution, governance rights and exit framework are not specified.
• Historical and projected operating data are owner-provided and require financial, tax and commercial diligence.
• Construction, commissioning, capex overrun and occupancy-ramp risks.
• Recruitment and retention of specialist doctors, nurses and clinical staff.
• Licensing, accreditation, clinical-quality, patient-safety and regulatory risks.
• Geographic concentration in Delhi-NCR and exposure to local competition.
• Payor-mix, government-reimbursement, insurer-collection and receivables risks.
• Execution risk associated with new specialties, oncology infrastructure and digital initiatives.

Public sources

Market context: Ministry of Health and Family Welfare, National Health Accounts Estimates for India 2021-22; National Health Mission, Indian Public Health Standards.